Trial reportPloS one2014
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.
Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Who cites it
20 citing papers in PubMed, 91 citations in OpenAlex.
- Trial
- Trial
- Tailoring Exercise Prescription for Effective Diabetes Glucose Management.The Journal of clinical endocrinology and metabolism · 2025Review
- Are Regular Aerobic Exercisers With Type 1 Diabetes Following Current Physical Activity Self-Management Guidelines? Insights From an Online Survey.Clinical diabetes : a publication of the American Diabetes Association · 2025Article
- Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review.Diabetologia · 2023Review
- Association of HbA1c with VOMetabolites · 2022Review
- Article
- Fear of hypoglycemia, a game changer during physical activity in type 1 diabetes mellitus patients.World journal of diabetes · 2021Review
- Carbohydrate Requirement for Exercise in Type 1 Diabetes: Effects of Insulin Concentration.Journal of diabetes science and technology · 2020Article
- Bolus insulin dose depends on previous-day race intensity during 5 days of professional road-cycle racing in athletes with type 1 diabetes: A prospective observational study.Diabetes, obesity & metabolism · 2020Observational
- The competitive athlete with type 1 diabetes.Diabetologia · 2020Review
- Review
- Resistance Isn't Futile: The Physiological Basis of the Health Effects of Resistance Exercise in Individuals With Type 1 Diabetes.Frontiers in endocrinology · 2019Review
- Exercise Testing in Individuals With Diabetes, Practical Considerations for Exercise Physiologists.Frontiers in physiology · 2019Review
- Basal insulin reductions in anticipation of multiple exercise sessions in people with type 1 diabetes-a clinical perspective.Annals of translational medicine · 2018Article
- Use of continuous glucose monitoring for sport in type 1 diabetes.BMJ open sport & exercise medicine · 2018Article
- Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association.Diabetes care · 2016Review
- The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study.Cardiovascular diabetology · 2015Observational
- Prevention of exercise-associated dysglycemia: a case study-based approach.Diabetes spectrum : a publication of the American Diabetes Association · 2015Article
- Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial.BMJ open diabetes research & care · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 3 institutions in 1 country.
Funding
Abstract
aimTo examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients.
methodsThis was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l-1) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg-1BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO2peak. At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg-1BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal.
resultsAll participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l-1; 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = -0.484, p = 0.017).
conclusionsHeavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances.
trial registrationClinicalTrials.gov NCT01531855.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.